Melisa Dirchwolf - Publications

Prospective surveillance reveals high rates of antimicrobial resistance in urinary tract infections among patients with cirrhosis.

Journal: Annals of hepatology

Published: April 25, 2025

Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines.

Journal: Journal of viral hepatitis

Published: January 22, 2025

Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group.

Journal: Annals of hepatology

Published: September 29, 2024

Editorial: Terlipressin and MDRO colonisation in cirrhosis-Is there a causal link?

Journal: Alimentary pharmacology & therapeutics

Published: April 23, 2024

Towards evidence-based empiric antibiotic recommendations for spontaneous infections in patients with cirrhosis.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 08, 2024

Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 05, 2024

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

Journal: Hepatology (Baltimore, Md.)

Published: December 07, 2023

Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.

Journal: Gastroenterology

Published: February 13, 2023

Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay.

Journal: Annals of hepatology

Published: January 06, 2023

Challenges and recommendations when selecting empirical antibiotics in patients with cirrhosis.

Journal: World journal of hepatology

Published: November 12, 2022

Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: October 21, 2022

Letter: what explains improved survival from statin exposure after liver transplantation? Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 23, 2022